Oculoplastics

CHICAGO — New target therapies and improvements in surgical techniques are leading to a change in the expectations and outcomes of patients with thyroid eye disease.

CHICAGO — There is room for improvement to make oculoplastics education materials more readable and accountable, according to a study presented here.

CHICAGO — Biologics are a game changer for the treatment of thyroid eye disease, according to one speaker at the American Academy of Ophthalmology meeting.

CHICAGO — Management of thyroid eye disease requires a carefully planned, personalized approach, according to Michael Kazim, MD, speaking at the American Academy of Ophthalmology meeting.

CHICAGO — OCT accurately staged skin cancers, allowing for better diagnosis of basal cell carcinoma, prediction of margins and improved planning for Mohs surgery, according to a study presented here.

CHICAGO — In a study aimed at verifying the safety and efficacy of in-office oral sedation for oculofacial surgeries, patients and physicians who used an ASC said postoperatively they would have preferred to be in the office.

CHICAGO — Eliminating the use of opioids in the postoperative management of oculofacial surgery produced better pain control and subsequent patient satisfaction than standard of care regimens that included opioids, a presenter said here.

MONTEREY, Calif. — For someone who is bothered by their low-lying eyelids, Upneeq may be an option, a speaker here told colleagues at the Women in Ophthalmology Summer Symposium.

A post-marketing safety analysis showed that the real-world rate of hearing-related events linked with Tepezza treatment was comparable to that found in clinical trials, according to a press release.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Femida Kherani, MD, reviews the “ABCs” of performing upper-lid blepharoplasties.